STAT Virtual Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D
Join STAT for a discussion with two VCs as they weigh in on what distinguishes great science from bad investments.
Editor’s note: A recording of the event is embedded below.
After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.
What's Your Reaction?
